News About: Pharm. Industry
Oriental doctors challenge sales ban of placenta extract preparations
A dispute has arisen over the sales ban of placenta extract preparations derived from pigs or sheep.
Oriental doctors have threatened to sue the government, saying placenta extract preparations have been safely use...
Green Cross launches sustained release vitamin C capsuleGreen Cross Corporation says it has launched C-mate SR, vitamin C sustained release capsule of which ingredient is imported from Eurand S.p.A of Italy.
According to GCC, the ...
|
DHP Korea and Dongwha enter agreement over Zabofloxacin
DHP Korea and Dongwha Pharmaceutical has recently announced an agreement granting DHP exclusive rights to develop and commercialize Zabofloxacin (DW224a) in the field of ophthalmology.
DHP plans to develop Zaboflox...
Choi receives management awardKwangdong Pharm Chairman Choi Soo-bu received a 2008 management award from the Daehan Association of Business Administration.
The management award has been given to business ...
|
Multinationals abuse Korea's patent trial system
Pfizer Korea and Sanofi-Aventis Korea have sought to prevent the insurance prices of their original medicine from being decreased by 20 percent, when a generic drug gets listed for insurance coverage, through a trial ...
Business lobby group calls for reforming pharmaceutical administration rules
Korea should revise regulations in the domestic pharmaceutical sector, said the Korea Pharmaceutical Industry Cooperative.
In a recent filing with the Regulatory Reform Committee, the cooperative said it is necessa...
Wholesalers wary of margin reduction
Drug wholesalers are closely watching pharmaceutical firms' movement to see if the current wholesaler margin is falling.
Wholesalers are watching pharmaceutical company's attempts to lower the margin, which will af...
Dispute rekindling over GSK margin issue
Tension has been escalating over the wholesaler margin issue of GlaxoSmithKline, who slashed its associate wholesaler margin by 1.5 percent last December.
In a meeting on April 31, the Pharmaceutical Development Co...
Dongwha teams up with Teijin over DW1350
Dongwha Pharm says on April 1 that it entered into a technology transfer agreement with Teijin Pharma under which Teijin will have exclusive rights to develop and commercialize a novel class of molecules for the treat...
New anti-hyperlipidemic substance found
We discovered the new physiological functions of chlorophyll water that is extracted from a number of plants, and expect that the water may be used as an ingredient for various industries, said Yoon Yong-chul, chairma...
